Key result
Olmesartan upregulated miR-205 and inhibited VEGF-A expression in HeLa and Siha cervical cancer cells, suggesting a novel anti-tumor mechanism.
Why the study?
Does olmesartan inhibit cervical cancer cell proliferation via modulation of miR-205 and VEGF-A?
Does olmesartan inhibit cervical cancer cell proliferation via modulation of miR-205 and VEGF-A?
Olmesartan demonstrates anti-tumor effects in cervical cancer cells by upregulating miR-205 and inhibiting VEGF-A, suggesting a potential novel therapeutic mechanism.
Answers are grounded in this paper and cite their sources.
No clinical implications yet; leaves open whether olmesartan affects cervical cancer progression in vivo.
OBJECTIVE: The renin-angiotensin-aldosterone system has become known as a prerequisite for tumor angiogenesis that is now recognized as a crucial step in the development of tumors, including cervical cancer. The Ang II-AT1R pathway is known to play an important role in tumor angiogenesis. MicroRNAs (miRNAs) are a class of small, regulating RNAs that participate in tumor genesis, differentiation and proliferation. The current study focused on the anti-tumor mechanism of olmesartan, a novel angiotensin II antagonist, on cervical cancer cells. MATERIALS AND METHODS: qRT-PCR and Western blot were used to demonstrate the effect of olmesartan on miR-205 and VEGF-A expression. miR-205 mimics and VEGF-A shRNA plasmid were separately transfected into HeLa and Siha cells to further validate the function of miR-205 and VEGF-A in cervical cancer cell proliferation. RESULTS: It was found that olmesartan could upregulate miR-205 and inhibit VEGF-A expression in HeLa and Siha cells. In addition, VEGF-A was proven to be a target gene of miR-205. CONCLUSION: This result provides a new idea on the anti-tumor mechanism of olmesartan, which may be used as a novel therapeutic target of cervical cancer.
No takes yet. Share an insight, caveat, or question.
Yue Zhang (2016) studied Cervical cancer. Olmesartan was evaluated on miR-205 and VEGF-A expression. Olmesartan upregulated miR-205 and inhibited VEGF-A expression in HeLa and Siha cervical cancer cells, suggesting a novel anti-tumor mechanism.
Synapse has enriched 10 related papers. Consider them for comparative context: